Form 424B2 ROYAL BANK OF CANADA Feb 9, 2026 09:07AM

 

   

Registration Statement No. 333-275898

Filed Pursuant to Rule 424(b)(2)

The information in this preliminary pricing supplement is not complete and may be changed.

     

Preliminary Pricing Supplement

Subject to Completion: Dated February 9, 2026

 

Pricing Supplement dated February __, 2026 to the Prospectus dated December 20, 2023, the Prospectus Supplement dated December 20, 2023 and... (continue reading...)


Form 25-NSE Lemonade, Inc. Filed by: NYSE AMERICAN LLC Feb 9, 2026 09:07AM

ATTACHMENTS / EXHIBITS

primary_doc.xml

ruleprovisionnotice.htm


Form 424B2 BANK OF MONTREAL /CAN/ Feb 9, 2026 09:07AM

 

Registration Statement No. 333-285508

Filed Pursuant to Rule 424(b)(2)

 

Amendment No. 41 dated February 9, 2026 to the Pricing Supplement dated January 22, 2018 to the Prospectus Supplement dated March 25, 2025 and the Prospectus dated March 25, 2025

 

Issued by Bank of Montreal

1,500,000 Notes

MicroSectors™ FANG+™ Index -3X Inverse Leveraged ETNs due January 8, 2038

 

This pricing supplement relates to the MicroSectors™ FANG+™ Index -3X... (continue reading...)


Form D/A 275 Funding, LLC Feb 9, 2026 09:07AM .FormData { color: blue; background-color: white; font-size: 12px; font-family: Times, serif; } .FormDataR { color: blue; background-color: white; font-size: 12px; font-family: Times, serif; text-align: right; } .SmallFormData { color: blue; background-color: white; font-size: 10px; font-family: Times, serif; } .FootnoteData { color:... (continue reading...)
Form ABS-15G Zolve Financials LLC For: Dec 31 Feb 9, 2026 09:06AM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM ABS-15G

ASSET-BACKED SECURITIZER REPORT

PURSUANT TO SECTION 15G OF THE

SECURITIES EXCHANGE ACT OF 1934

Check the appropriate box to indicate the filing obligation to which this form is intended to satisfy:

☐ Rule 15Ga-1(c)(1) under the Exchange Act (17 CFR 240.15Ga-1(c)(1)) for the reporting period to

☐ Rule 15Ga-1(c)(2)(i) under the Exchange Act (17 CFR 240.15Ga-1(c)(2)(i))... (continue reading...)


More SEC Filings

View Older Stories

Feb 9, 2026 09:05AM Form 424B2 BANK OF MONTREAL /CAN/
Feb 9, 2026 09:04AM Form FWP National Bank Holdings Filed by: National Bank Holdings Corp
Feb 9, 2026 09:04AM Form 6-K ParaZero Technologies For: Feb 09
Feb 9, 2026 09:04AM Form 8-K SM Energy Co For: Feb 04
Feb 9, 2026 09:03AM Form F-1/A Horizon Thread (PTY)
Feb 9, 2026 09:03AM Form 497J FT 12718
Feb 9, 2026 09:02AM Form 497J FT 12782
Feb 9, 2026 09:01AM Form 497J FT 12742
Feb 9, 2026 09:01AM Form SCHEDULE 13D/A Commercial Vehicle Group Filed by: Lakeview Opportunity Fund LLC
Feb 9, 2026 09:00AM Form 8-K FB Bancorp, Inc. /MD/ For: Feb 09
Feb 9, 2026 09:00AM Form 8-K Valaris Ltd For: Feb 09
Feb 9, 2026 09:00AM Form SCHEDULE 13G/A Ryerson Holding Corp Filed by: JB CAPITAL PARTNERS LP
Feb 9, 2026 09:00AM Form 6-K Diginex Ltd For: Jan 30
Feb 9, 2026 09:00AM Form 6-K Energys Group Ltd For: Feb 09
Feb 9, 2026 09:00AM Form 6-K ASCENTAGE PHARMA GROUP For: Feb 09
Feb 9, 2026 09:00AM Form 8-K TriSalus Life Sciences, For: Feb 03
Feb 9, 2026 09:00AM Form 497J FT 12741
Feb 9, 2026 08:59AM Form 13F-HR Catalyst Funds Managemen For: Dec 31
Feb 9, 2026 08:59AM Form 8-K SYNCHRONOSS TECHNOLOGIES For: Feb 09
Feb 9, 2026 08:59AM Form 497J FT 12739
Feb 9, 2026 08:59AM Form 424B5 National Bank Holdings
Feb 9, 2026 08:58AM Form 13F-HR Fox Financial, Inc For: Dec 31
Feb 9, 2026 08:57AM Form SCHEDULE 13G/A Liquidia Corp Filed by: Farallon Capital Partners, L.P.
Feb 9, 2026 08:56AM Form 13F-HR Darden Wealth Group Inc For: Dec 31
Feb 9, 2026 08:55AM Form 8-K Limitless X Holdings For: Jan 26
Feb 9, 2026 08:55AM Form SCHEDULE 13G/A AGIOS PHARMACEUTICALS, Filed by: Farallon Capital Partners, L.P.
Feb 9, 2026 08:54AM Form 13F-HR OLD REPUBLIC INTERNATION For: Dec 31
Feb 9, 2026 08:53AM Form SCHEDULE 13G/A Revolution Medicines, Filed by: Farallon Capital Partners, L.P.
Feb 9, 2026 08:53AM Form SCHEDULE 13G/A LIFETIME BRANDS, INC Filed by: JB CAPITAL PARTNERS LP
Feb 9, 2026 08:53AM Form 8-K Nukkleus Inc. For: Feb 09
Feb 9, 2026 08:52AM Form 8-K AVANT TECHNOLOGIES INC. For: Feb 03
Feb 9, 2026 08:51AM Form TA-2 NORTHEAST INVESTORS TRUS For: Dec 31
Feb 9, 2026 08:51AM Form SCHEDULE 13G/A Beta Bionics, Inc. Filed by: Farallon Capital Partners, L.P.
Feb 9, 2026 08:50AM Form 3 Entera Bio Ltd. For: Feb 04 Filed by: Germano Geno J
Feb 9, 2026 08:50AM Form 6-K VODAFONE GROUP PUBLIC For: Feb 09
Feb 9, 2026 08:49AM Form SCHEDULE 13G/A GRAIL, Inc. Filed by: Farallon Capital Partners, L.P.
Feb 9, 2026 08:47AM Form SCHEDULE 13G/A Fluent, Inc. Filed by: JB CAPITAL PARTNERS LP
Feb 9, 2026 08:47AM Form SCHEDULE 13G/A ASSEMBLY BIOSCIENCES, Filed by: Farallon Capital Partners, L.P.
Feb 9, 2026 08:46AM Form 8-K Entera Bio Ltd. For: Feb 04
Feb 9, 2026 08:46AM Form 8-K BITMINE IMMERSION TECHNO For: Feb 09
Feb 9, 2026 08:45AM Form 8-K Turn Therapeutics Inc. For: Feb 09
Feb 9, 2026 08:40AM Form 4 SOUTHERN CO For: Feb 05 Filed by: Poroch David P.
Feb 9, 2026 08:39AM Form 4 SOUTHERN CO For: Feb 05 Filed by: Cherry Pedro P.
Feb 9, 2026 08:39AM Form 4 SOUTHERN CO For: Feb 05 Filed by: Kim Matthew M.
Feb 9, 2026 08:37AM Form 6-K Cadeler A/S For: Feb 09
Feb 9, 2026 08:36AM Form 8-K SHF Holdings, Inc. For: Feb 04
Feb 9, 2026 08:36AM Form 10-K Ladder Capital Corp For: Dec 31
Feb 9, 2026 08:35AM Form 144 Business First Bancshare Filed by: Folse Mark P.
Feb 9, 2026 08:35AM Form 8-K LABCORP HOLDINGS INC. For: Feb 06
Feb 9, 2026 08:35AM Form 13F-NT Viola Growth Management For: Dec 31
View Older Stories